Why is Astrazeneca Phar falling/rising?

As of 01-Jul, Astrazeneca Pharma India Ltd's stock price is currently at 8,890.00, reflecting a decrease of -2.7, or -0.03%. The stock has been experiencing a consecutive decline over the past two days, with a total drop of -0.16% during this period. Despite this recent downturn, the stock has shown strong performance over the longer term, with a 1-month return of +11.53% and a year-to-date increase of +21.20%. Key factors influencing the stock include high management efficiency, evidenced by a return on equity (ROE) of 19.06%, and a significant net profit growth of 88.82% reported in March 2025. However, the stock is facing challenges such as a high price-to-book value ratio and a decline in institutional investor participation, which may be contributing to the recent price movement.
In the broader market context, Astrazeneca's short-term performance has lagged behind the benchmark Sensex, which has increased by +2.00% over the past week compared to the stock's +1.63% gain. This underperformance relative to the benchmark may be influencing investor sentiment. Additionally, while the stock has shown consistent returns over the last three years, the concerns regarding its high valuation and declining institutional interest could be impacting its current price trajectory. Overall, the combination of strong fundamentals and recent price declines suggests a complex interplay of factors affecting investor confidence in Astrazeneca Pharma India Ltd.